Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Efferent manifestations of multiple sclerosis.
Management of fatigue in persons with multiple sclerosis.
Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.
ANALYSIS OF MULTIPLE SCLEROSIS LESIONS VIA SPATIALLY VARYING COEFFICIENTS.
Deep breathing exercises with positive expiratory pressure in patients with multiple sclerosis - a randomized controlled trial.
Sphingosine 1-phosphate signaling at the blood-brain barrier.
Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.
Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.
Clinicopathological features in anterior visual pathway in neuromyelitis optica.
Nutrition and Lifestyle Intervention on Mood and Neurological Disorders.
Regulation: The FDA is overcautious on consumer genomics.
Seasonal vitamin D changes and the impact on health risk assessment.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
Quantitative proteome profiling of CNS-infiltrating autoreactive CD4(+) cells reveals selective changes during experimental autoimmune encephalomyelitis.
Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology.
Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain.
Visual Evoked Potential and Magnetic Resonance Imaging are More Effective Markers of Multiple Sclerosis Progression than Laser Polarimetry with Variable Corneal Compensation.
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.
Multiple sclerosis. Recent modalities of treatment.
Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis.
Botulinum Toxin-What Urologic Uses Does the Data Support?
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review.
Oral disease-modifying therapies for relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
446
447
448
449
450
451
452
453
454
…
next ›
last »